OTCPK:SRBZ.F

Stock Analysis Report

Executive Summary

STRATEC SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally.

Snowflake

Fundamentals

Established dividend payer with reasonable growth potential.


Similar Companies

Share Price & News

How has STRATEC Biomedical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

SRBZ.F

1.9%

US Medical Equipment

0.4%

US Market


1 Year Return

n/a

SRBZ.F

15.6%

US Medical Equipment

6.9%

US Market


Shareholder returns

SRBZ.FIndustryMarket
7 Day0%1.9%0.4%
30 Day0%-1.7%-1.1%
90 Day0.4%-0.03%-0.5%
1 Yearn/a16.5%15.6%9.3%6.9%
3 Yearn/a72.1%66.9%45.8%36.4%
5 Yearn/a125.8%100.8%62.9%45.1%

Price Volatility Vs. Market

How volatile is STRATEC Biomedical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is STRATEC Biomedical undervalued compared to its fair value and its price relative to the market?

43.66x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Information is not available.

Information is not available.


Price To Earnings Ratio

Information is not available.

Information is not available.


Price to Earnings Growth Ratio

Information is not available.


Price to Book Ratio

Information is not available.


Next Steps

Future Growth

How is STRATEC Biomedical forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

27.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Information is not available.

Information is not available.

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Information is not available.

Information is not available.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has STRATEC Biomedical performed over the past 5 years?

6.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Information is not available.

Information is not available.

Information is not available.


Return on Equity

Information is not available.


Return on Assets

Information is not available.


Return on Capital Employed

Information is not available.


Next Steps

  • Explore strong past performing companies in the Healthcare industry.

Financial Health

How is STRATEC Biomedical's financial position?


Financial Position Analysis

Information is not available.

Information is not available.


Debt to Equity History and Analysis

Information is not available.

Information is not available.

Information is not available.

Information is not available.


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is STRATEC Biomedical's current dividend yield, its reliability and sustainability?

1.41%

Current Dividend Yield


Dividend Yield vs Market

company1.4%marketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Years1.3%

Current dividend yield vs market & industry


Stability and Growth of Payments

Information is not available.

Information is not available.

Stable Dividend: SRBZ.F's dividends per share have been stable in the past 10 years.

Information is not available.


Current Payout to Shareholders

Information is not available.


Future Payout to Shareholders

Information is not available.


Next Steps

Management

What is the CEO of STRATEC Biomedical's salary, the management and board of directors tenure and is there insider trading?

7.6yrs

Average management tenure


CEO

Marcus Wolfinger (51yo)

7.6yrs

Tenure

€874,000

Compensation

Mr. Marcus Wolfinger has been Chairman of Management Board and Chief Executive Officer at STRATEC Biomedical AG since April 01, 2011 and its Member of the Management Board since July 1999. Mr. Wolfinger ha ...


CEO Compensation Analysis

Information is not available.

Information is not available.


Management Age and Tenure

7.6yrs

Average Tenure

51yo

Average Age

Information is not available.


Insider Trading

Information is not available.


Ownership Breakdown


Management Team

  • Marcus Wolfinger (51yo)

    Chairman of Board of Management & CEO

    • Tenure: 7.6yrs
    • Compensation: €874.00k
  • Robert Siegle (51yo)

    Director of Finance & Human Resources and Member of Board of Management

    • Tenure: 7.8yrs
    • Compensation: €612.00k
  • Hermann Leistner (72yo)

    Founder & Advisor

    • Tenure: 7.7yrs
  • Andre Loy

    Director of Corporate Communications

    • Tenure: 0yrs
  • Claus Vielsack (51yo)

    Director of Product Development & Member of Board of Management

    • Tenure: 4.8yrs
    • Compensation: €566.00k
  • Roland Utz

    Head of Supply Chain Management & Senior VP

    • Tenure: 0yrs
  • Sandra Eberle

    Head of Investor Relations

    • Tenure: 0yrs

Board Members

  • Fred Brückner (75yo)

    Chairman of the Supervisory Board

    • Tenure: 0yrs
    • Compensation: €54.00k
  • Stefanie Remmele (40yo)

    Member of the Supervisory Board

    • Tenure: 4.4yrs
    • Compensation: €29.00k
  • Rainer Baule (70yo)

    Deputy Chairman of Supervisory Board

    • Tenure: 1.4yrs

Company Information

Stratec SE's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Stratec SE
  • Ticker: SRBZ.F
  • Exchange: OTCPK
  • Founded: 1979
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €661.167m
  • Listing Market Cap: €757.264m
  • Shares outstanding: 11.96m
  • Website: https://www.stratec.com

Number of Employees


Location

  • Stratec SE
  • Gewerbestrasse 35-37
  • Birkenfeld
  • 75217
  • Germany

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SBSDB (Deutsche Boerse AG)YesRegistered SharesDEEUROct 1998
SBSSWX (SIX Swiss Exchange)YesRegistered SharesCHCHFOct 1998
SBSXTRA (XETRA Trading Platform)YesRegistered SharesDEEUROct 1998
SRBZ.FOTCPK (Pink Sheets LLC)YesRegistered SharesUSUSDOct 1998
0RARLSE (London Stock Exchange)YesRegistered SharesGBEUROct 1998
SBSDBATS-CHIXE (BATS 'Chi-X Europe')YesRegistered SharesGBEUROct 1998

Biography

STRATEC Biomedical AG designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2018/11/19 22:36
End of Day Share Price2018/08/24 00:00
Earnings2018/09/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.